These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 18673207)

  • 1. Therapeutic strategy of erythropoietin in neurological disorders.
    Liu XB; Wang JA; Yu SP; Keogh CL; Wei L
    CNS Neurol Disord Drug Targets; 2008 Jun; 7(3):227-34. PubMed ID: 18673207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythropoietin as a novel neuroprotectant.
    Genc S; Koroglu TF; Genc K
    Restor Neurol Neurosci; 2004; 22(2):105-19. PubMed ID: 15272145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The brain erythropoietin system and its potential for therapeutic exploitation in brain disease.
    Hasselblatt M; Ehrenreich H; Sirén AL
    J Neurosurg Anesthesiol; 2006 Apr; 18(2):132-8. PubMed ID: 16628067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythropoietin 2nd cerebral protection after acute injuries: a double-edged sword?
    Velly L; Pellegrini L; Guillet B; Bruder N; Pisano P
    Pharmacol Ther; 2010 Dec; 128(3):445-59. PubMed ID: 20732352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin update 2011.
    Kowalczyk M; Banach M; Mikhailidis DP; Rysz J
    Med Sci Monit; 2011 Nov; 17(11):RA240-247. PubMed ID: 22037755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Derivatives of erythropoietin that are tissue protective but not erythropoietic.
    Leist M; Ghezzi P; Grasso G; Bianchi R; Villa P; Fratelli M; Savino C; Bianchi M; Nielsen J; Gerwien J; Kallunki P; Larsen AK; Helboe L; Christensen S; Pedersen LO; Nielsen M; Torup L; Sager T; Sfacteria A; Erbayraktar S; Erbayraktar Z; Gokmen N; Yilmaz O; Cerami-Hand C; Xie QW; Coleman T; Cerami A; Brines M
    Science; 2004 Jul; 305(5681):239-42. PubMed ID: 15247477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of erythropoietin in the brain.
    Noguchi CT; Asavaritikrai P; Teng R; Jia Y
    Crit Rev Oncol Hematol; 2007 Nov; 64(2):159-71. PubMed ID: 17482474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin (epoetin) as a protective factor for the brain.
    Malhotra S; Nijhawan S; Rosenbaum DM
    Curr Atheroscler Rep; 2004 Jul; 6(4):301-6. PubMed ID: 15191705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system.
    Sirén AL; Fasshauer T; Bartels C; Ehrenreich H
    Neurotherapeutics; 2009 Jan; 6(1):108-27. PubMed ID: 19110203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoietin and the nervous system.
    Genc S; Koroglu TF; Genc K
    Brain Res; 2004 Mar; 1000(1-2):19-31. PubMed ID: 15053948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current perspectives on protective roles of erythropoietin in cardiovascular system: erythropoietin receptor as a novel therapeutic target.
    Kagaya Y; Asaumi Y; Wang W; Takeda M; Nakano M; Satoh K; Fukumoto Y; Shimokawa H
    Tohoku J Exp Med; 2012 Jun; 227(2):83-91. PubMed ID: 22688525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-erythroid functions of erythropoietin.
    Gassmann M; Heinicke K; Soliz J; Ogunshola OO
    Adv Exp Med Biol; 2003; 543():323-30. PubMed ID: 14713131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic benefit of a combined strategy using erythropoietin and endothelial progenitor cells after transient focal cerebral ischemia in rats.
    Pellegrini L; Bennis Y; Guillet B; Velly L; Garrigue P; Sabatier F; Dignat-George F; Bruder N; Pisano P
    Neurol Res; 2013 Nov; 35(9):937-47. PubMed ID: 23816235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The nasal route as a potential pathway for delivery of erythropoietin in the treatment of acute ischemic stroke in humans.
    Garcia-Rodriguez JC; Sosa-Teste I
    ScientificWorldJournal; 2009 Sep; 9():970-81. PubMed ID: 19768354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Erythropoietin and neuroprotection].
    Chatagner A; Hüppi PS; Ha-Vinh Leuchter R; Sizonenko S
    Arch Pediatr; 2010 Sep; 17 Suppl 3():S78-84. PubMed ID: 20728813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of erythtropoietin in cerebral diseases.
    Cotena S; Piazza O; Tufano R
    Panminerva Med; 2008 Jun; 50(2):185-92. PubMed ID: 18607342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medicine. A boost for translational neuroscience.
    Ehrenreich H
    Science; 2004 Jul; 305(5681):184-5. PubMed ID: 15247460
    [No Abstract]   [Full Text] [Related]  

  • 18. Erythropoietin for neonatal brain injury: opportunity and challenge.
    Xiong T; Qu Y; Mu D; Ferriero D
    Int J Dev Neurosci; 2011 Oct; 29(6):583-91. PubMed ID: 21277366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietin in the central nervous system, and its use to prevent hypoxic-ischemic brain damage.
    Juul S
    Acta Paediatr Suppl; 2002; 91(438):36-42. PubMed ID: 12477263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The neuroprotective effect of erythropoietin-transduced human mesenchymal stromal cells in an animal model of ischemic stroke.
    Cho GW; Koh SH; Kim MH; Yoo AR; Noh MY; Oh S; Kim SH
    Brain Res; 2010 Sep; 1353():1-13. PubMed ID: 20547143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.